Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination

被引:31
|
作者
Bridle, Byram W. [1 ]
Nguyen, Andrew [2 ]
Salem, Omar [2 ]
Zhang, Liang [2 ]
Koshy, Sandeep [2 ]
Clouthier, Derek [2 ]
Chen, Lan [2 ]
Pol, Jonathan [2 ]
Swift, Stephanie L. [2 ]
Bowdish, Dawn M. E. [2 ]
Lichty, Brian D. [2 ]
Bramson, Jonathan L. [2 ]
Wan, Yonghong [2 ]
机构
[1] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada
[2] McMaster Univ, McMaster Immunol Res Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
来源
JOURNAL OF IMMUNOLOGY | 2016年 / 196卷 / 11期
基金
加拿大健康研究院;
关键词
DENDRITIC CELLS; MARGINAL ZONE; MARABA VIRUS; LYMPH-NODES; EFFECTOR; ACTIVATION; EXPRESSION; NAIVE; LOCALIZATION; GENERATION;
D O I
10.4049/jimmunol.1600106
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Effector T cells (T-EFF) are a barrier to booster vaccination because they can rapidly kill Ag-bearing APCs before memory T cells are engaged. We report in this study that i.v. delivery of rhabdoviral vectors leads to direct infection of follicular B cells in the spleen, where the earliest evidence of secondary T cell responses was observed. This allows booster immunizations to rapidly expand CD8(+) central memory T cells (T-CM) during the acute phase of the primary response that is dominated by TEFF. Interestingly, although the ablation of B cells before boosting with rhabdoviral vectors diminishes the expansion of memory T cells, B cells do not present Ags directly. Instead, depletion of CD11c(+) dendritic cells abrogates secondary T cell expansion, suggesting that virus-infected follicular B cells may function as an Ag source for local DCs to subsequently capture and present the Ag. Because TCM are located within B cell follicles in the spleen whereas TEFF cannot traffic through follicular regions, Ag production and presentation by follicular APCs represent a unique mechanism to secure engagement of TCM during an ongoing effector response. Our data offer insights into novel strategies for rapid expansion of CD8(+) T cells using prime-boost vaccines by targeting privileged sites for Ag presentation.
引用
收藏
页码:4587 / 4595
页数:9
相关论文
共 50 条
  • [41] Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
    McAuliffe, James
    Chan, Hok Fung
    Noblecourt, Laurine
    Ramirez-Valdez, Ramiro Andrei
    Pereira-Almeida, Vinnycius
    Zhou, Yaxuan
    Pollock, Emily
    Cappuccini, Federica
    Redchenko, Irina
    Hill, Adrian V. S.
    Leung, Carol Sze Ki
    Van den Eynde, Benoit J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [42] Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition
    A de Mare
    A J A Lambeck
    J Regts
    G M van Dam
    H W Nijman
    H Snippe
    J Wilschut
    T Daemen
    Gene Therapy, 2008, 15 : 393 - 403
  • [43] Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
    He, Ran
    Yang, Xinxin
    Liu, Cheng
    Chen, Xiangyu
    Wang, Lin
    Xiao, Minglu
    Ye, Jianqiang
    Wu, Yuzhang
    Ye, Lilin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15 (09) : 815 - 826
  • [44] Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
    Xie, L.
    He, R.
    Wang, Y.
    Luo, Y.
    Ye, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 394 - 395
  • [45] Viral vector-based prime-boost immunization regimens: a possible involvement of T-cell competition
    de Mare, A.
    Lambeck, A. J. A.
    Regts, J.
    van Dam, G. M.
    Nijman, H. W.
    Snippe, H.
    Wilschut, J.
    Daemen, T.
    GENE THERAPY, 2008, 15 (06) : 393 - 403
  • [46] T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
    C S Rollier
    E J Verschoor
    B E Verstrepen
    J A R Drexhage
    G Paranhos-Baccala
    P Liljeström
    G Sutter
    L Arribillaga
    J J Lasarte
    B Bartosch
    F-L Cosset
    G Inchauspe
    J L Heeney
    Gene Therapy, 2016, 23 : 753 - 759
  • [47] B cell antigen presentation plays a limited role in primary and secondary CD4 T cell responses
    Wu, Gregory
    Archambaul, Angela
    McGee, Gretchen
    Dragatsis, Ioannis
    Allenspach, Eric
    Raabe, Tobias
    Russell, John
    Laufer, Terri
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [48] T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates
    Rollier, C. S.
    Verschoor, E. J.
    Verstrepen, B. E.
    Drexhage, J. A. R.
    Paranhos-Baccala, G.
    Liljestrom, P.
    Sutter, G.
    Arribillaga, L.
    Lasarte, J. J.
    Bartosch, B.
    Cosset, F-L
    Inchauspe, G.
    Heeney, J. L.
    GENE THERAPY, 2016, 23 (10) : 753 - 759
  • [49] An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
    Nicolas, Alexandre
    Sannier, Geremy
    Dube, Mathieu
    Nayrac, Manon
    Tauzin, Alexandra
    Painter, Mark M.
    Goel, Rishi R.
    Laporte, Melanie
    Gendron-Lepage, Gabrielle
    Medjahed, Halima
    Williams, Justine C.
    Brassard, Nathalie
    Niessl, Julia
    Gokool, Laurie
    Morrisseau, Chantal
    Arlotto, Pascale
    Tremblay, Cecile
    Martel-Laferriere, Valerie
    Finzi, Andres
    Greenplate, Allison R.
    Wherry, E. John
    Kaufmann, Daniel E.
    ISCIENCE, 2023, 26 (01)
  • [50] T cell and antibody responses in HIV-1 seronegative volunteers immunized with recombinant canarypox and pg120 prime-boost vaccines.
    Tellez, I
    Sabbaj, S
    Peng, X
    Mulligan, MJ
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 137A - 137A